No exonic mutations at GJB2, GJB3, GJB4, GJB6, ARS (Component B), and LOR genes responsible for a Chinese patient affected by progressive symmetric erythrokeratodermia with pseudoainhum

Int J Dermatol. 2014 Sep;53(9):1111-3. doi: 10.1111/ijd.12494. Epub 2014 Jun 25.

Abstract

Objective: Progressive symmetric erythrokeratodermia (PSEK) is characterized by symmetric and growing erythematous hyperkeratotic patches over the body shortly after birth, particularly trunk and limbs, the buttocks, and the face, sometimes together with palmoplantar keratoderma (PPK). The GJB2, GJB3, GJB4, GJB6, ARS (Component B), and LOR gene mutation might contribute to PSEK manifestation. This study aimed to identify sequence alteration of these genes in a Chinese PSEK patient with pseudoainhum.

Methods: Genomic DNA was purified from the patient's peripheral blood. Mutation analysis of target genes was performed by direct sequencing using ABI 3730 sequencer

Results: No exonic mutations was identified in the aforementioned genes.

Conclusions: The result underlines the genetic heterogeneity of PSEK and other related erythrokeratodermas.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Ainhum / genetics*
  • Antigens, Ly / genetics
  • Asian People / genetics
  • China
  • Connexin 26
  • Connexin 30
  • Connexins / genetics
  • Constriction, Pathologic / genetics*
  • Erythrokeratodermia Variabilis / genetics*
  • Genes, pX / genetics
  • Humans
  • Male
  • Mutation
  • Sequence Analysis, DNA
  • Urokinase-Type Plasminogen Activator / genetics

Substances

  • Antigens, Ly
  • Connexin 30
  • Connexins
  • GJB2 protein, human
  • GJB6 protein, human
  • SLURP1 protein, human
  • Connexin 26
  • GJB3 protein, human
  • connexin 30.3
  • Urokinase-Type Plasminogen Activator

Supplementary concepts

  • Pseudoainhum